Literature DB >> 24238235

Consensus statement for the diagnosis and treatment of drug-induced lung injuries.

Keishi Kubo1, Arata Azuma, Minoru Kanazawa, Hideto Kameda, Masahiko Kusumoto, Akihiko Genma, Yasuo Saijo, Fumikazu Sakai, Yukihiko Sugiyama, Koichiro Tatsumi, Makoto Dohi, Hitoshi Tokuda, Shu Hashimoto, Noboru Hattori, Masayuki Hanaoka, Yuh Fukuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24238235     DOI： 10.1016/j.resinv.2013.09.001

Source DB:  PubMed          Journal:  Respir Investig        ISSN： 2212-5345


× No keyword cloud information.
  62 in total

1.  Cost-Effectiveness of Second-Line Endocrine Therapies in Postmenopausal Women with Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Metastatic Breast Cancer in Japan.

Authors:  Verin Lertjanyakun; Nathorn Chaiyakunapruk; Susumu Kunisawa; Yuichi Imanaka
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

2.  Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database.

Authors:  Takuya Imatoh; Kimie Sai; Chisato Fukazawa; Yasushi Hinomura; Ryosuke Nakamura; Yoshimi Okamoto-Uchida; Katsunori Segawa; Yoshiro Saito
Journal:  Eur J Clin Pharmacol       Date:  2017-08-22       Impact factor: 2.953

3.  Severe drug-induced interstitial lung disease successfully treated with corticosteroid plus recombinant human soluble thrombomodulin.

Authors:  Satoshi Marumo; Masahiro Shirata; Minoru Sakuramoto; Motonari Fukui
Journal:  BMJ Case Rep       Date:  2014-12-17

Review 4.  A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature.

Authors:  Yinhong Zhang; Xiaoyan Wang; Yang Cheng; Xiaofang Wang; Yunjian Zhang
Journal:  BMC Pulm Med       Date:  2022-07-19       Impact factor: 3.320

5.  Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease.

Authors:  Tetsuo Fujita; Tsuguko Kuroki; Nami Hayama; Yuka Shiraishi; Hiroyuki Amano; Makoto Nakamura; Satoshi Hirano; Hiroshi Tabeta; Sukeyuki Nakamura
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

6.  Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

Authors:  Kota Murohashi; Yu Hara; Yusuke Saigusa; Nobuaki Kobayashi; Takashi Sato; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

Review 7.  Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer.

Authors:  Kohei Shitara; Eishi Baba; Kazumasa Fujitani; Eiji Oki; Satoshi Fujii; Kensei Yamaguchi
Journal:  Gastric Cancer       Date:  2021-05-16       Impact factor: 7.370

8.  Pazopanib-associated interstitial lung disease in a patient with renal cell carcinoma.

Authors:  Yukinori Harada; Shintaro Kakimoto; Taro Shimizu
Journal:  BMJ Case Rep       Date:  2020-07-08

Review 9.  Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.

Authors:  Shin Takayama; Takao Namiki; Hiroshi Odaguchi; Ryutaro Arita; Akito Hisanaga; Kazuo Mitani; Takashi Ito
Journal:  Front Pharmacol       Date:  2021-06-23       Impact factor: 5.810

10.  Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells.

Authors:  Takamichi Ojima; Masashi Kawami; Ryoko Yumoto; Mikihisa Takano
Journal:  Toxicol Res       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.